Rheumatology

Molecular signatures in systemic lupus erythematosus: distinction between disease flare and infection.

Mackay M, Oswald M, Sanchez-Guerrero J, Lichauco J, Aranow C, Kotkin S, Korsunsky I, Gregersen PK, Diamond B

READ MORE   

APLAR rheumatoid arthritis treatment recommendations

Yang SS, Lau CS, Chia F, Harrison A, Hsieh TY, Jain R, Jung SM, Kishimoto M, Kumar A, Leong KP, Li Z, Lichauco JJ, Louthrenoo W, Luo SF, Nash P, Park SH, Suryana BP, Wijaya LK, Yamamoto K, Yang Y, Asia Pacific League of Associations for Rheumatology

READ MORE   

Survey of rheumatologists on the use of the Philippine Guidelines on the Screening for Tuberculosis prior to use of Biologic Agents

Lichauco JJ, Aquino-Villamin M, Tankeh-Torres S

A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study

Yoo DH, Racewicz A, Brzezicki J, Yatsyshyn R, Baranauskaite A, Abud-Mendoza C, Navarra S, Kadinov V, Sariego IG, Hong SS, Lee SY, Park W, Arteaga ET

APLAR rheumatoid arthritis treatment recommendations

Yang SS, Lau CS, Chia F, Harrison A, Hsieh TY, Jain R, Jung SM, Kishimoto M, Kumar A, Leong KP, Li Z, Lichauco JJ, Louthrenoo W, Luo SF, Nash P, Park SH, Suryana BP, Wijaya LK, Yamamoto K, Yang Y, Asia Pacific League of Associations for Rheumatology

Molecular signatures in systemic lupus erythematosus: distinction between disease flare and infection.

Mackay M, Oswald M, Sanchez-Guerrero J, Lichauco J, Aranow C, Kotkin S, Korsunsky I, Gregersen PK, Diamond B